Cue Health (NSDQ:HLTH) announced today that it will launch its direct-to-consumer virtual health program on Nov. 15, 2021.
San Diego-based Cue Health’s virtual health platform includes what it says is a first-of-its kind molecular COVID-19 test through its new eCommerce site and in-app shop. The company said in a news release that it makes the COVID-19 test that has been used by organizations including Google, Mayo Clinic, the NBA, the MLB and others, available to individual consumers.
“We’ve had a lot of interest from the general public eager to purchase our COVID-19 tests: from parents who need to keep their kids healthy in school to international business travelers to families who want to gather safely this holiday season,” Cue Health Co-Founder & Chief Product Officer Clint Sever said in the release. “We’re excited to make Cue available to a broader audience next week to deliver fast and accurate COVID-19 testing at home or on the go.”
Along with the COVID-19 testing, which has FDA authorization for at-home use without a prescription, Cue’s membership offering — Cue+ — will offer 24-hour on-demand access to board-certified physicians, e-prescription services, CDC-compliant test results for travel through in-app video proctoring and same-day delivery of Cue products across a range of major markets.
Cue+ allows users to share Cue test results and discuss other health issues with a doctor on-demand through the company’s new Cue Health App.
“We’re pleased to be able to offer consumers our best-in-class COVID-19 tests as part of Cue’s integrated care platform, which we believe can help empower individuals and families to live their healthiest lives,” Cue Helath Co-Founder & CEO Ayub Khattak said. “With Cue+ membership and our new Cue Health App, we aim to make the healthcare journey — from testing to diagnosis to treatment — more accessible, more convenient, and more timely.”